Clinical Trials Browser

NIH × Rectal Neoplasms × MK 2206 × Clear all

NCT01802320 2019-09-20

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Phase 2 Completed

18 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms